NCT06607393 CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3] Status COMPLETED Phase N/A
NCT06607185 A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06594874 A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Participants with KRAS G12C Mutation Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT06591650 Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer Status RECRUITING Phase PHASE2
NCT06585189 CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS4] Status COMPLETED Phase N/A
NCT06571708 Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT) Status RECRUITING Phase PHASE2
NCT06564844 A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06561685 A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT06561386 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1% Status RECRUITING Phase PHASE3
NCT06551142 A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD) Status RECRUITING Phase PHASE1
NCT06548412 CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers Status RECRUITING Phase PHASE1/PHASE2
NCT06546969 Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer Status RECRUITING Phase PHASE1
NCT06543576 External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06535607 Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors Status RECRUITING Phase PHASE2
NCT06532279 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer Status RECRUITING Phase PHASE2
NCT06531447 First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06524544 A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer Status RECRUITING Phase PHASE3
NCT06511726 Induction Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06510465 Neoadjuvant Therapy With Weekly Utidelone Combined With Cisplatin for Patients With Breast Cancer (NeoURANIA) Status NOT_YET_RECRUITING Phase PHASE2
NCT06493552 Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors Status RECRUITING Phase PHASE2/PHASE3